- Home
- 应用程序分析
- WHO Contraception tool
- WHO Contraception tool Vs. STI Tx Guide
WHO Contraception tool 对比 STI Tx Guide 的使用情况和统计数据
This tool is the digital version of the MEC Wheel. It contains the medical eligibility criteria for starting use of contraceptive methods, based on Medical Eligibility Criteria for Contraceptive Use, 5th edition (2015), one of WHO’s evidence-based guidelines. It guides family planning providers in recommending safe and effective contraception methods for women with medical conditions or medically-relevant characteristics.
The tool includes recommendations on initiating use of nine common types of contraceptive methods:
1. Combined pills, COC (low dose combined oral contraceptives, with ≤ 35 μg ethinyl estradiol)
2. Combined contraceptive patch, P
3. Combined contraceptive vaginal ring, CVR
4. Combined injectable contraceptives, CIC
5. Progestogen-only pills, POP
6. Progestogen-only injectables, DMPA (IM,SC)/NET-EN (depot medroxyprogesterone acetate intramuscular or subcutaneous or norethisterone enantate intramuscular)
7. Progestogen-only implants, LNG/ETG (levonorgestrel or etonogestrel)
8. Levonorgestrel-releasing intrauterine device, LNG-IUD
9. Copper-bearing intrauterine device, Cu-IUD
- Apple 应用商店
- 免费
- 医疗
商店排名
- -
The new app offers quick and easy access to streamlined STI prevention, diagnosis, and treatment recommendations. The user-friendly interface includes more clinical care guidance, sexual history resources, patient materials, and other features to assist with patient management.
The STI Treatment (Tx) Guidelines mobile app serves as a quick reference guide for doctors and related parties on the identification of and treatment for sexually transmitted diseases (STDs). The full STI Treatment Guidelines (cdc.gov) can be accessed at https://www.cdc.gov/std/treatment-guidelines/default.htm. The guidelines provide current evidence-based prevention, diagnostic and treatment recommendations that replace the 2015 guidance. The recommendations are intended to be a source for clinical guidance. Healthcare providers should always assess patients based on their clinical circumstances and local burden.
DISCLAIMER
THE MATERIALS EMBODIED IN THIS SOFTWARE IS PROVIDED TO YOU "AS-IS" AND WITHOUT WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR OTHERWISE, INCLUDING WITHOUT LIMITATION, ANY WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE. IN NO EVENT SHALL THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) OR THE UNITED STATES (U.S.) GOVERNMENT BE LIABLE TO YOU OR ANYONE ELSE FOR ANY DIRECT, SPECIAL, INCIDENTAL, INDIRECT OR CONSEQUENTIAL DAMAGES OF ANY KIND, OR ANY DAMAGES WHATSOEVER, INCLUDING WITHOUT LIMITATION, LOSS OF PROFIT, LOSE OF USE, SAVINGS OR REVENUE, OR THE CLAIMS OF THIRD PARTIES, WHETHER OR NOT CDC OR THE U.S. GOVERNMENT HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH LOSS, HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, ARISING OUT OF OR IN CONNECTION WITH THE POSSESSION, USE OR PERFORMANCE OF THIS SOFTWARE.
- Apple 应用商店
- 免费
- 医疗
商店排名
- -
WHO Contraception tool与STI Tx Guide排名比较
对比 WHO Contraception tool 与 STI Tx Guide 在过去 28 天内的排名趋势
排名
没有可用的数据
WHO Contraception tool 对比 STI Tx Guide 的排名,按国家/地区比较
对比 WHO Contraception tool 与 STI Tx Guide 在过去 28 天内的排名趋势
所有品类
没有可用的数据
医疗
通过免费试用版比较任何网站
WHO Contraception tool VS.
STI Tx Guide
十二月 10, 2024